Two weeks ago in New York FSG launched its new research on creating shared value in global health, Competing by Saving Lives, in New York. The event brought together more than 100 representatives from the pharmaceutical and medical device industries, and from key global health stakeholders. The attendees heard Prof. Michael Porter launch the findings of the report, and then engaged in a lively discussion that built on the key recommendations, including a panel with representatives from BD, Abbott, and Novartis, moderated by Jane Nelson of the Harvard Kennedy School.